Urology · Houston, TX
NPI
1073567376
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
6560 Fannin St, Suite#1440
Houston, TX, 77030
Phone (713) 790-9700
Groups this clinician bills Medicare through
Medicare paid, 2024
$460K
15,450 services
Medicare patients, 2024
1,254
Average age 76
Drug cost, 2024
$501K
5,726 prescriptions
Company payments, 2025
$8,100
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen L Lapin was code 81003 (clinical chemistry), 1,581 times for 1,074 patients. In total Stephen L Lapin billed 15,450 services in 97 codes, and Medicare paid $460K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81003 Clinical Chemistry | Office | 1,581 | 1,074 | $2.20 | $3,478 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,274 | 269 | $50.26 | $64K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,100 | 11 | $0.10 | $113 |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 1,050 | 19 | $45.09 | $47K |
| 51798 Ultrasound - Nonspecific | Office | 973 | 734 | $8.24 | $8,022 |
| 36415 Venipuncture Blood Collection | Office | 842 | 656 | $8.39 | $7,067 |
| 99214 Office E&M - Established | Office | 836 | 605 | $90.80 | $76K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 815 | 650 | $12.46 | $10K |
| 99213 Office E&M - Established | Office | 775 | 623 | $67.98 | $53K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 445 | 211 | $39.32 | $17K |
| 99204 Office E&M - New | Office | 129 | 129 | $114.03 | $15K |
| 99442 Telephone Services | Office | 79 | 74 | $65.76 | $5,195 |
| 52000 Cystourethroscopy | Facility | 77 | 73 | $62.75 | $4,831 |
| 99232 Hospital E&M - Subsequent | Facility | 74 | 33 | $64.07 | $4,741 |
| 51720 Chemotherapy Administration | Office | 59 | 13 | $68.98 | $4,070 |
By year: 2022 $356K for 10,413 services; 2023 $379K for 11,659 services; 2024 $460K for 15,450 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,581 | 1,074 | $2.20 | $3,478 |
| 36415 Venipuncture Blood Collection | 842 | 656 | $8.39 | $7,067 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen L Lapin prescribed most often to Medicare patients was Finasteride, with 1,734 prescriptions and refills. In total Stephen L Lapin wrote 5,726 Medicare prescriptions that cost $501K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Finasteride Generic | 1,734 | 5,040 | 509 | $28K |
| Tamsulosin Hcl Generic | 1,421 | 3,941 | 435 | $26K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 328 | 934 | 107 | $7,822 |
| Myrbetriq Mirabegron | 296 | 592 | 92 | $263K |
| Dutasteride Generic | 267 | 727 | 94 | $9,151 |
| Testosterone Cypionate Generic | 130 | 217 | 39 | $6,238 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 116 | 119 | 97 | $1,646 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 115 | 131 | 89 | $610 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 109 | 112 | 70 | $853 |
| Cefdinir Generic | 98 | 100 | 75 | $1,375 |
| Estradiol Generic | 95 | 251 | 52 | $8,193 |
| Testosterone Generic | 85 | 122 | 20 | $16K |
| Ciprofloxacin Hcl Generic | 84 | 84 | 64 | $341 |
| Silodosin Generic | 72 | 173 | 19 | $8,182 |
| Levofloxacin Generic | 69 | 69 | 51 | $273 |
Brand drugs: 402 claims; generic drugs: 5,324 claims; opioid claims: 47.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen L Lapin $8,100 ($8,100 in general payments such as food, travel and fees) from 28 companies. The largest payer was HMU Consumables, LLC with $5,143.
| Company | Payments | Amount |
|---|---|---|
| HMU Consumables, LLC | 2 | $5,143 |
| Sumitomo Pharma America, Inc. 4506.T | 49 | $358 |
| Boston Scientific Corporation BSX | 4 | $327 |
| Ferring Pharmaceuticals Inc. | 11 | $249 |
| Pfizer Inc. PFE | 7 | $218 |
| Janssen Biotech, Inc. JNJ | 8 | $210 |
| Endo USA, Inc. | 9 | $195 |
| Antares Pharma, Inc. | 20 | $165 |
| Abbvie Inc. ABBV | 7 | $161 |
| Progenics Pharmaceuticals, Inc. | 5 | $128 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.